Browsing: Investing

By Ben Glickman Shares of CVRx rose after the medical-device company’s revenue jumped 70% in the third quarter. The stock was up 17% to $15 in…

By Ben Glickman Eli Lilly said the U.S. Food and Drug Administration had approved Omvoh, its treatment for moderately to severely active ulcerative colitis in adults.…

By Stephen Nakrosis Shares of Merit Medical Systems were higher in Thursday’s late-trading market, after the company reported higher earnings per share and revenue in the…

By Josh Beckerman Boise Cascade declared a $5 special dividend, a larger payout than the company’s similar dividends in recent years. The company, a maker of…

Hello! This week’s ETF Wrap gives you a look at the findings in Charles Schwab’s latest annual ETF survey as well as how Thursday’s economic data…

Higher interest rates have made big home-improvement projects such as adding solar panels more expensive. Courtesy Enphase Enphase Energy projected that the current slowdown in solar-product…

Ford’s earnings might be the least important thing discussed by the company. Lukas Schulze/Getty Images Ford Motor stock is falling after its third-quarter results came in…

Shares of Amazon are up 44% in 2023. Justin Sullivan/Getty Images Amazon shares gained ground after the company posted better-than-expected financial results for the September quarter.…

‍The traditional 60/40 investment portfolio, a staple of American retirement planning, has been taking a beating since the start of 2022. Incredibly, even during a bear…

Sam Bankman-Fried, founder and former CEO of defunct crypto exchange FTX, testified at his criminal fraud trial on Thursday without the jury present. Judge Lewis Kaplan…